| Trade Name | KYORIN Pharmaceutical Co., Ltd. |
|---|---|
| Main Business | Manufacture, sale and purchases of prescription medicines |
| Location of Head Quarter | 6, Kanda Surugadai 4-Chome, Chiyoda-ku, Tokyo 101-8311 Japan |
| Telephone | 03-3525-4700 |
| Founding | 1923 |
| Paid-in Capital | 700 million yen |
| Listing | Tokyo Stock Exchange |
Board of Directors and Corporate Auditors
| Representative Director, Chairman | Minoru Hogawa |
|---|---|
| Representative Director, President and Chief Executive Officer |
Yutaka Ogihara |
| Executive Director, CMO | Michiro Onota |
| Executive Director(outside) | Noriyuki Shikanai Ken Shigematsu Hiromi Watanabe |
| Audit & Supervisory Board Member | Tomiharu Matsumoto Kenji Akutsu |
| Audit & Supervisory Board Member (outside) | Takao Yamaguchi Yukio Ikemura Kensuke Morita |
Corporate Officer
| Corporate Officer CStO & CFO, Director of Corporate Planning |
Yasuji Kurose |
|---|---|
| Corporate Officer CBDO, Senior Director of Business Development HQs |
Takaaki Kaji |
| Corporate Officer CCO, Senior Director of Sales & Marketing HQs |
Noriaki Tamura |
| Corporate Officer CSO, Senior Director of Discovery Research HQs |
Junichi Ishiyama |
| Corporate Officer CHRO, Director of General Affairs |
Kiyoo Uehara |
| Senior Corporate Officer, Senior Director of SCM HQs |
Kei Takahashi |
| Corporate Officer, President of KYORIN Rimedio Co., Ltd. |
Hiroshi Hashizume |
| Corporate Officer, Deputy Senior Director of Business Development HQs |
Makoto Yanai |
| Corporate Officer, Senior Director of Quality Assurance & Reliability HQs |
Katsuhiro Hamada |
| Corporate Officer, Executive Director and Vice President of KYORIN Rimedio Co., Ltd. |
Kenichi Nakamura |
| Corporate Officer, Director of Product Strategy |
Kimiya Masada |
Organization
